OTC Markets OTCQB - Delayed Quote USD

Kraig Biocraft Laboratories, Inc. (KBLB)

Compare
0.0900
-0.0020
(-2.17%)
At close: January 14 at 3:00:00 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kim Kraig Thompson Founder, Chairman, CEO, President, CFO & Corporate Secretary 594.07k -- 1961
Mr. Jonathan R. Rice Chief Operating Officer 204.32k -- 1980
Mr. Kenneth Le Director of Government Relations & President of Prodigy Textiles 60k -- 1966
Dr. Trevor L. Kane Chief Scientist & Member of Scientific Advisory Board -- -- --

Kraig Biocraft Laboratories, Inc.

2723 South State Street
Suite 150
Ann Arbor, MI 48104
United States
734 619 8066 https://www.kraiglabs.com
Full Time Employees: 
37

Description

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Corporate Governance

Kraig Biocraft Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 31, 2025 at 8:00 PM UTC - April 4, 2025 at 8:00 PM UTC

Kraig Biocraft Laboratories, Inc. Earnings Date

Recent Events

December 19, 2024 at 12:00 AM UTC

AW: Withdrawal of amendment to a registration statement filed under the Securities Act

December 9, 2024 at 12:00 AM UTC

S-1/A: Offering Registrations

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 29, 2024 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

May 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 1, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 22, 2023 at 12:00 AM UTC

S-1/A: Offering Registrations

November 13, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 1, 2023 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Related Tickers